Results 191 to 200 of about 3,371,263 (384)

Advancing the measurement of psychotherapy outcomes for youth with irritability using in vivo ecological momentary assessment: an exploratory observational study

open access: yesChild and Adolescent Mental Health, EarlyView.
Background Ecological momentary assessment (EMA) can reveal naturalistic within‐person changes in symptoms and behaviors, essential for examining psychotherapy's effectiveness. However, no prior study has leveraged EMA to assess real‐time, naturalistic changes of clinical symptoms during psychotherapy in youth with clinically impairing irritability ...
Reut Naim   +6 more
wiley   +1 more source

Comparison of the Effects of Clozapine, Olanzapine and Risperidone with Haloperidol on Fasting Blood Level of Glucose, Cholesterol and Triglyceride in Patients with Psychotic Disorders

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009
BACKGROUND AND OBJECTIVE: Atypical antipsychotic drugs are first line treatment for psychotic disorders and well tolerated by the patients because of less extra pyramidal side effects and better efficacies. But there are different reports about metabolic
A Masoudzadeh   +3 more
doaj  

Comparison of Cardiovascular Effects of a New Antipsychotic Agent Aripiprazole with Those of Haloperidol

open access: diamond, 2000
Yoshioki Satoh   +3 more
openalex   +1 more source

Documentation of Drug and Non‐Drug Allergies in Public Hospital Electronic Health Records: A National Survey

open access: yesClinical &Experimental Allergy, EarlyView.
These surveys reveal inconsistent electronic patient record (EPR) systems and poor documentation standards for non‐drug allergies, leading to high incident rates and misclassification. Standardised documentation, improved training and user‐friendly EPR platforms are urgently needed to enhance patient safety and reduce allergy‐related incidents across ...
Melvin Lee Qiyu   +2 more
wiley   +1 more source

Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists for incident dementia: A retrospective multicohort study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Objective This study provides real‐world evidence on the comparative effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) regarding the risk of incident dementia in adults with type 2 diabetes mellitus (T2DM).
Filippos Anagnostakis   +4 more
wiley   +1 more source

Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: A novel series of atypical antipsychotic agents

open access: green, 2010
Chul Min Park   +4 more
openalex   +1 more source

Association between glucagon‐like peptide‐1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Type 2 diabetes (T2D) is associated with increased dementia risk, but comparative data across newer glucose‐lowering therapies remain limited. We examined whether the initiation of GLP‐1 receptor agonists (GLP‐1 RAs) was associated with incident dementia compared with DPP4 inhibitors (DPP4is) and SGLT2 inhibitors (SGLT2is) in older adults ...
Ting Zhou   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy